Potentiation of etoposide induced apoptosis by staurosporine in human tumor cells is associated with events downstream of DNA-protein complex formation

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 5, 1997, Pages 399-409

  Lock, Richard B ^a   Thompson, Bruce S ^a   Sullivan, Daniel M ^b   Stribinskiene, Lolita ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Etoposide; Staurosporine; Topoisomerase II; Tyrosine kinase

Indexed keywords

CYCLIN DEPENDENT KINASE; ETOPOSIDE; GYRASE INHIBITOR; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; STAUROSPORINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA PROTEIN COMPLEX; DNA SYNTHESIS; DRUG POTENTIATION; HELA CELL; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR;

APOPTOSIS; BREAST NEOPLASMS; CDC2 PROTEIN KINASE; CDC2-CDC28 KINASES; CELL LINE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ETOPOSIDE; FEMALE; HELA CELLS; HUMANS; KINETICS; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0031041847     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050590     Document Type: Article

References (60)

1. Allen LM (1978) Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4′-demethyl epipodophyllotoxin thenylidene-β-D-glucoside and 4′-demethyl epipodophyllotoxin ethylidene-β-D-glucoside. in the L1210 leukemia cell. Cancer Res 38:2549
2. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wildtype p53. Science 249:912
3. Baloch Z, Cohen S, Fresa K, Coffman FD (1995) Modulation of topoisomerase activities by tumor necrosis factor. Cell Immunol 160:98
4. Bartek J, Iggo R, Gannon J, Lane DP (1990) Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893
5. Bertrand R, Solary E, Jenkins J, Pommier Y (1993) Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp Cell Res 207:388
6. Chambers TC, McAvoy EM, Jacobs JW, Eilon G (1990) Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 265:7679
7. Chang WP, Little JB (1991) Delayed reproductive death in X-irradiated Chinese hamster ovary cells. Int J Radiat Biol 60:483
8. Chen AY, Liu LF (1994) DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191
9. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156
10. Crissman HA, Gadbois DM, Tobey RA, Bradbury EM (1991) Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. Proc Natl Acad Sci USA 88:7580
11. DeVita VTJ, Hellman S, Rosenberg SA (1993) Cancer: principles and practice of oncology, 4th edn. J.B. Lippincott Co., Philadelphia
12. DeVore RF, Corbett AH, Osheroff N (1992) Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage religation and sensitivity to the antineoplastic drugs etoposide and 4′-(9-acridinylamino)methane-sulfon-m-anisidide. Cancer Res 52:2156
13. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E. Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817
14. 1 arrest and apoptosis. Cancer Res 54:1169
15. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119
16. Findik D, Song Q, Hidaka H, Lavin M (1995) Protein kinase A inhibitors enhance radiation-induced apoptosis. J Cell Biochem 57:12
17. Fine RL, Patel J, Chabner BA (1988) Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 85:582
18. cdc2-like kinases. Biochem Biophys Res Commun 184:80
19. Gewirtz DA, Orr MS, Fornari FA, Randolph JK, Yalowich JC, Ritke MK, Povirk LF, Bunch RT (1993) Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression. Cancer Res 53:3547
20. Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD (1994) Modulation of 1-[β-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Oncol Res 6:87
21. Grieder A, Maurer R, Stahelin H (1974) Effect of an epipodophyllotoxin derivative (VP-16-213) on macromolecular synthesis and mitosis in mastocytoma cells in vitro. Cancer Res 34:1788
22. Hashimoto H, Chatterjee S, Berger NA (1995) Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression. Cancer Res 55:4029
23. Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11:121
24. Johnson M, Dimitrov D, Vojta PJ, Barrett JC, Noda A, Pereira-Smith OM, Smith JR (1994) Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1 p21 RNA in human cells. Mol Carcinog 11:59
25. Kalwinsky DA, Look AT, Ducore J, Fridland A (1983) Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts. Cancer Res 43:1592
26. Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J (1993) bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res 53:4251
27. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304
28. Kerr JFR, Winterford CM, Harmon BV (1994) Apoptosis: Its significance in cancer and cancer therapy. Cancer 73:2013
29. Laredo J, Huynh A, Muller C, Jaffrezou J-P, Bailly J-D, Cassar G, Laurent G, Demur C (1994) Effect of the protein kinase C inhibitor staurosporine on chemosensitivity to daunorubicin of normal and leukemic fresh myeloid cells. Blood 84:229
30. cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Res 52:1817
31. cdc2/cyclin-B kinase in relation to cell cycle perturbations induced by etoposide. Int J Oncol 3:33
32. 2 arrest in Chinese hamster ovary cells. Cancer Res 50:3761
33. cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Res 50:3767
34. Lock RB, Galperina OV, Feldhoff RC, Rhodes LJ (1994) Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res 54:4933
35. Long BH, Musial ST, Brattain MG (1985) Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res 45:3106
36. Lotem J, Sachs L (1993) Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemia cells. Cell Growth Differ 4:41
37. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957
38. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K. Vogelstein B, Jacks T (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935
39. Meikrantz W, Gisselbrecht S, Tam SW, Schlegel R (1994) Activation of cyclin A-dependent kinases during apoptosis. Proc Natl Acad Sci USA 91:3754
40. Mirski SEL, Evans CD, Almquist KC, Slovak ML, Cole SPC (1993) Altered topoisomerase IIα in a drug-resistant small cell lung cancer cell line selected in VP-16. Cancer Res 53:4866
41. Nukano H, Kobayashi E, Takahashi I, Tamaoki T, Kuzuu Y, Iba H (1987) Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60. J Antibiot 40:706
42. Norbury C, Nurse P (1992) Animal cell cycles and their control. Annu Rev Biochem 61:441
43. Norbury C, MacFarlane M, Fearnhead H, Cohen GM (1994) CDC2 activation is not required for thymocyte apoptosis. Biochem Biophys Res Commun 202:1400
44. Rodilla V (1993) Origin and evolution of binucleated cells and binucleated cells with micronuclei in cisplatin-treated CHO cultures. Mutat Res 300:281
45. Rubin E, Kharbanda S, Gunji H, Kufe D (1991) Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide. Mol Pharmacol 39:697
46. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press., New York
47. Scheffner M, Munger K, Byrne JC, Howley PM (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523
48. cdc2 activation required for apoptosis. Science 263:1143
49. Shimizu T, O'Connor PM, Kohn KW, Pommier Y (1995) Unscheduled activation of cyclin B1/cdc2 kinase in human promyclocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res 55:228
50. Strasser A, Harris AW, Jacks T, Cory S (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79:329
51. Swarup G, Cohen S, Garbers DL (1982) Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun 107:1104
52. ++dependent protein kinase. Biochem Biophys Res Commun 135:397
53. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456
54. Tishler RB, Calderwood SK, Coleman CN, Price BD (1993) Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 53:2212
55. Tounekti O, Pron G, Belehradek J, Mir LM (1993) Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53:5462
56. Webb CD, Latham MD, Lock RB, Sullivan DM (1991) Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line. Cancer Res 51:6543
57. Wood AC, Elvin P, Hickman JA (1995) Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br J Cancer 71:937
58. lyn kinase in human myeloid leukemia cells. Biochemistry 34:1058
59. Zwelling LA, Chan D, Hinds M, Mayes J, Silberman LE, Blick M (1988) Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Cancer Res 48:6625
60. Zwelling LA, Altschuler E, Mayes J, Hinds M, Chan D (1991) The effect of staurosporine on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Cancer Chemother Pharmacol 29:48